12 October 2020 in Russian Journal of Spine Surgery (Khirurgiya Pozvonochnika)
Лечебно-диагностическая ценность трансфораминальных эпидуральных блокад у пациентов с грыжами межпозвонкового диска и корешковой болью: аналитический обзор литературы
7 August 2026 in Burdenko's Journal of Neurosurgery
Background. Traditional histological classification of meningiomas has low prognostic accuracy and necessitates integration of molecular biomarkers. However, current data are fragmented and require rigorous synthesis. Objective. To develop a meta-analysis protocol for quantitative assessment of the influence of molecular profile of meningiomas on long-term outcomes (overall survival and recurrence-free period) after surgical or combined treatment. Material and methods. The article provides historical analysis of transformation of evidence-based medicine standards from narrative reviews to algorithmic guidelines (QUOROM, MOOSE, PRISMA). The choice of the PRISMA-P 2020 protocol and Cochrane methodology as the standard for this study is justified. Results. A meta-analysis design was developed to assess the impact of genetic profile (TERT, CDKN2A/B, NF2 status, DNA methylation) on the risk of recurrence. Inclusion criteria (PICOTS) cover all types of meningiomas. The protocol regulates searching strategy, independent screening (Rayyan) and risk of bias assessment using the QUIPS tool. Statistical synthesis of data is planned to identify the hierarchy of risk factors. Conclusion. Implementation of this protocol will ensure creation of a valid evidence base for stratification of risk of meningioma recurrence based on molecular genetic profile.
3 January 2024 in Siberian journal of oncology
Introduction. Meningioma is one of the most common central nervous system tumors, accounting for 39.7 % of all primary brain tumors. The tumor originates from arachnoid meningothelial cells and is characterized by a wide range of histological types classified into 15 subtypes. The histological classification of meningiomas allows us to predict meningioma behavior and the risk of disease recurrence, as well as to define treatment strategies. However, clinical outcomes in histological subgroups of patients are often inconsistent with the histological grade of malignancy. Thus, a more reliable method is needed both to determine the histological subtype of the tumor and to predict the clinical course of the disease with the potential for targeted treatment.The purpose of the study was to summarize the available data on the effect of results of the genomic and proteomic tumor analysis on carcinogenesis with the relationship between the mutational changes and noninvasive diagnosis, treatment and the course of the disease.Material and Methods. Literature search was carried out in the PubMed, Elibrary system, publications were included mainly from 2010 to 2023. with the identification of articles by the keyword “genetic analysis of meningiomas” and synonyms. 550 articles were found, of which 55 were used to write a literature review.Conclusion. The study of the molecular genetic profile of meningiomas will improve the classification and establish a correlation with MRI data, the course of the disease and prognosis.
20 September 2023 in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
MNMoscow Federal State Budgetary Scientific Institution «Scientific Center Of Neurology»
Moscow Federal State Budgetary Scientific Institution «Scientific Center Of Neurology»
+4
Aim of the research. To study the efficacy and safety of treating patients with cervical radicular pain that is resistant to conservative treatment. Material and methods. The results of treatment of 30 patients with herniated discs of the cervical spine and persistent radicular pain syndrome, who had an indication for surgical treatment, were studied. All subjects underwent transforaminal epidural block (TEB), and in case of its low efficiency, the patients were offered surgical treatment. The patients'condition was assessed in dynamics over 2 years, including on the basis of indicators of the visual analog scale (VAS), the Neck Disability Index (NDI) questionnaire, and motor dysfunction in the limb according to the MRC Scale for Muscle Strength (MRC). Results. After 1 month: 21 (70 %) patients noted a significant (at least 50 %), persistent decrease in the intensity of radicular pain during the first month after TEB; a decrease in NDI values was noted in all patients. In 83.3 % (n-10) of the patients, there was a complete recovery of motor function in the limb. Two (6.7 %) patients underwent surgical treatment. After 24 months: All patients maintained a decrease in NDI scores (median 4 [0;6]). In 21 (70 %) patients, a stable positive effect from the conducted TEB remained. Four (13.3 %) patients were operated on, while five (16.7 %) patients refused surgical treatment and continued conservative treatment with a positive effect over time. Thus, all patients showed a significant decrease in the intensity of radicular and local pain in the neck with a median of 0 [0;0]. A complete restoration of muscle strength was found in all patients with moderate paresis of the arm before manipulation (n-12). Only 5 patients (16.7 %) retained periodic moderate (not exceeding 3 points by the VAS) local pain in the neck, and four (13.3 %) patients noted periodic, mild (not exceeding 3 points by the VAS) radicular pain. Conclusion. The use of TEB in the treatment of patients with radiculopathy caused by herniated discs of the cervical spine prevents the need for surgical treatment in 70 % of the patients, while maintaining a high quality of life.
16 October 2026 in Burdenko's Journal of Neurosurgery
Background. Evolution of the WHO classification for meningiomas demonstrates a shift towards integrative approach, where molecular markers are essential for risk stratification. However, their prognostic significance depending on histological grade requires further clarification. Objective. To evaluate the impact of TERT promoter mutations and CDKN2A/B deletions on meningioma recurrence, stratified by tumor grade. Material and methods. A systematic review and meta-analysis (PRISMA-P) of 17 cohort studies (n=5867) was conducted. Random-effect models and network meta-analysis were employed to assess overall survival (OS) and progression-free survival (PFS). Results. The TERT mutation significantly worsens prognosis (OS HR=2.78; PFS HR=2.63), but the effect is context-dependent. In WHO Grade 1–2 tumors, it acts as a potent driver of aggression (HR~5.00, “initiation effect”), whereas in Grade 3 its contribution diminishes (HR~1.5) amidst general genomic instability. Homozygous deletion of CDKN2A/B is confirmed as a universal marker of early recurrence (HR=3.72) with up to 5-fold risk increment. Sensitivity analysis revealed that clonal mutations (detected by Sanger sequencing) hold greater prognostic value than subclonal ones (detected by NGS). Conclusion. TERT screening is essential for WHO Grade 1 and 2 meningiomas to identify occult aggression, while CDKN2A/B assessment is a priority for Grade 3 tumors.
1 January 2022 in P.A. Herzen Journal of Oncology
Глиомы представляют собой наиболее распространенную группу первичных опухолей головного мозга, составляя не менее 80% от всех типов неоплазий центральной нервной системы. Особого внимания заслуживают глиомы высокой степени злокачественности (анапластическая астроцитома и олигодендроглиома, анапластическая плеоморфная ксантоастроцитома, а также три молекулярно-генетических подтипа глиобластом) ввиду наличия неблагоприятного прогноза для выживаемости пациентов. Поиск источников литературы в отечественных и зарубежных базах данных продемонстрировал наличие нескольких исследований, посвященных изучению новых методов лечения при глиомах высокой степени злокачественности головного мозга, в том числе и при глиобластомах. Объединение результатов указанных исследований и явилось побудительным моментом к написанию данного обзора литературы.